(Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (Q4)Sep 30, 2020 | |
---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||
Cash flow from continuing operating activities | 0 | -68.59K | -49.06K | -9.76K |
Net income from continuing operations | --0 | ---56.49K | ---40.68K | ---44.19K |
Change In working capital | --0 | ---12.1K | ---8.38K | --34.43K |
-Change in prepaid assets | --0 | ---- | ---- | --0 |
-Change in payables and accrued expense | --0 | --9.16K | ---8.38K | --34.43K |
Cash from discontinued investing activities | ||||
Operating cash flow | --0 | ---68.59K | ---49.06K | ---9.76K |
Investing cash flow | ||||
Cash flow from continuing investing activities | 0 | -7.25K | -87.83K | -62.4K |
Net PPE purchase and sale | ---- | --0 | --0 | ---15K |
Net other investing changes | --0 | ---7.25K | ---87.83K | ---47.4K |
Cash from discontinued investing activities | ||||
Investing cash flow | --0 | ---7.25K | ---87.83K | ---62.4K |
Financing cash flow | ||||
Cash flow from continuing financing activities | 0 | 0 | 34K | 438.01K |
Net common stock issuance | --0 | --0 | --34K | --440K |
Net other financing activities | ---- | ---- | ---- | ---1.99K |
Cash from discontinued financing activities | ||||
Financing cash flow | --0 | --0 | --34K | --438.01K |
Net cash flow | ||||
Beginning cash position | --187.12K | --262.97K | --365.85K | --0 |
Current changes in cash | --0 | ---75.84K | ---102.89K | --365.85K |
End cash Position | --187.12K | --187.12K | --262.97K | --365.85K |
Free cash from | --0 | ---68.59K | ---49.06K | ---24.76K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data